- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/14 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 263/14
Total number of patents in this class: 71
10-year publication summary
|
2
|
4
|
3
|
6
|
2
|
4
|
3
|
2
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Chemical Company, Limited | 9092 |
3 |
| Epitech Group S.r.l. | 22 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 863 |
3 |
| Toyama Chemical Co., Ltd. | 101 |
3 |
| Oncternal Therapeutics, Inc. | 38 |
3 |
| Celltaxis, LLC | 27 |
3 |
| Amgen Inc. | 4122 |
2 |
| FUJIFILM Corporation | 29713 |
2 |
| Nankai University | 240 |
2 |
| Sirna Therapeutics, Inc. | 110 |
2 |
| Sun Chemical B.V. | 368 |
2 |
| Transitions Optical, Inc. | 252 |
2 |
| Zhejiang University of Technology | 262 |
2 |
| L'OREAL, Société Anonyme | 15731 |
1 |
| The Regents of the University of California | 20153 |
1 |
| AstraZeneca AB | 2872 |
1 |
| Mars, Incorporated | 2930 |
1 |
| Massachusetts Institute of Technology | 10121 |
1 |
| BioLab Ltd. | 5 |
1 |
| Cadila Healthcare Limited | 314 |
1 |
| Other owners | 32 |